https://scholars.lib.ntu.edu.tw/handle/123456789/612559
Title: | A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma | Authors: | Qin S. Chan S.L. Sukeepaisarnjaroen W. Han G. Choo S.P. Sriuranpong V. Pan H. Yau T. Guo Y. Chen M. Ren Z. Xu J. Yen C.-J. ZHONG-ZHE LIN Manenti L. Gu Y. Sun Y. Tiedt R. Hao L. Song W. Tanwandee T. |
Issue Date: | 2019 | Publisher: | SAGE Publications Inc. | Journal Volume: | 11 | Source: | Therapeutic Advances in Medical Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076565560&doi=10.1177%2f1758835919889001&partnerID=40&md5=0dc5aeb27bbe0cae43b92c9a0f0d4c28 https://scholars.lib.ntu.edu.tw/handle/123456789/612559 |
ISSN: | 1758-8340 | DOI: | 10.1177/1758835919889001 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.